文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

全基因组测序用于中国结核病耐药监测及耐药水平判定

Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China.
PubMed 文献 · Clin Microbiol Infect · 2021-09-30

本研究以4880株结核分枝杆菌分离株为对象,用全基因组测序(WGS)预测十种抗结核药物的耐药性,并与表型药敏试验比较。WGS对异烟肼、利福平、乙胺丁醇耐药预测灵敏度至少92.92%,对吡嗪酰胺灵敏度50.52%,对六种二线药物灵敏度85.05%–96.01%;特定突变可区分高/低水平耐药。WGS可作为结核病耐药监测和制定治疗方案的重要工具。

要点

  • WGS对异烟肼、利福平、乙胺丁醇耐药预测灵敏度高(≥92.92%)。
  • WGS对吡嗪酰胺耐药预测灵敏度仅50.52%,需谨慎解读。
  • rpoB S450L、katG S315T、gyrA D94G常致高水平耐药。

核心结论

  • WGS可高精度预测表型药敏,并可用于结核病耐药监测和耐药水平判定。

研究设计与样本

  • 研究对4880株结核分枝杆菌分离株用WGS检测十种抗结核药物耐药性,吡嗪酰胺采用BACTEC MGIT 960法。
  • 通过比较WGS预测的耐药患病率与表型药敏试验确定的真实患病率来评估WGS准确性。
  • 采用Student-Newman-Keuls检验确认突变对应的MIC差异。

主要发现

  • WGS预测异烟肼、利福平和乙胺丁醇耐药的灵敏度至少92.92%(95%CI 88.19–97.65)。
  • WGS预测吡嗪酰胺耐药的灵敏度为50.52%(95%CI 40.57–60.47)。
  • WGS预测六种二线药物耐药的灵敏度为85.05%(95%CI 80.27–89.83)至96.01%(95%CI 93.89–98.13)。
  • rpoB S450L、katG S315T和gyrA D94G突变始终导致高水平耐药。
  • rpoB L430P、rpoB L452P、fabG1 C-15T和embB G406S突变常导致低水平耐药或MIC升高至流行病学 cutoff(ECOFF)水平。

临床怎么用

  • WGS可用于结核病耐药监测,并辅助制定个体化治疗方案。
  • 对吡嗪酰胺耐药预测灵敏度较低,WGS结果需结合表型药敏谨慎判读。
  • 特定突变可提示耐药水平,有助于区分高水平和低水平耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Phenotypic drug susceptibility testing for prediction of tuberculosis (TB) drug resistance is slow and unreliable, limiting individualized therapy and monitoring of national TB data. Our study evaluated whole-genome sequencing (WGS) for its predictive accuracy, use in TB drug-resistance surveillance and ability to quantify the effects of resistance-associated mutations on MICs of anti-TB drugs. METHODS: We used WGS to measure the susceptibility of 4880 isolates to ten anti-TB drugs; for pyrazinamide, we used BACTEC MGIT 960. We determined the accuracy of WGS by comparing the prevalence of drug resistance, measured by WGS, with the true prevalence, determined by phenotypic susceptibility testing. We used the Student-Newman-Keuls test to confirm MIC differences of mutations. RESULTS: Resistance to isoniazid, rifampin and ethambutol was highly accurately predicted with at least 92.92% (95% confidence interval [CI], 88.19-97.65) sensitivity, resistance to pyrazinamide with 50.52% (95% CI, 40.57-60.47) sensitivity, and resistance to six second-line drugs with 85.05% (95% CI, 80.27-89.83) to 96.01% (95% CI, 93.89-98.13) sensitivity. The rpoB S450L, katG S315T and gyrA D94G mutations always confer high-level resistance, while rpoB L430P, rpoB L452P, fabG1 C-15T and embB G406S often confer low-level resistance or sub-epidemiological cutoff (ECOFF) MIC elevation. CONCLUSION: WGS can predict phenotypic susceptibility with high accuracy and could be a valuable tool for drug-resistance surveillance and allow the detection of drug-resistance level; It can be an important approach in TB drug-resistance surveillance and for determining therapeutic schemes.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Liu D, Huang F, Zhang G, et al. Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. Clin Microbiol Infect. 2021. PMID: 34600118. doi:10.1016/j.cmi.2021.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。